Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 185

    1.

    Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.

    Burris S, Lurie P, Abrahamson D, Rich JD.

    Ann Intern Med. 2000 Aug 1;133(3):218-26.PMID: 10906838 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?

    Lurie P, Jones TS, Foley J.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S45-51.PMID: 9663623 [PubMed - indexed for MEDLINE]Related articles

    3.

    The legality of selling or giving syringes to injection drug users.

    Burris S, Vernick JS, Ditzler A, Strathdee S.

    J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S13-8.PMID: 12489604 [PubMed - indexed for MEDLINE]Related articles

    4.

    The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.

    Gostin LO.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S60-70.PMID: 9663626 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.

    Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8.PMID: 9663636 [PubMed - indexed for MEDLINE]Related articles

    6.

    A syringe prescription program to prevent infectious disease and improve health of injection drug users.

    Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD.

    J Urban Health. 2004 Mar;81(1):122-34.PMID: 15047791 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island.

    Rich JD, Whitlock TL, Towe CW, McKenzie M, Runarsdottir V, Aboagye-Kumi M, Burris S.

    Subst Use Misuse. 2001 Apr;36(5):535-50.PMID: 11419486 [PubMed - indexed for MEDLINE]Related articles

    8.

    Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group.

    Diaz T, Chu SY, Weinstein B, Mokotoff E, Jones TS.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S76-81.PMID: 9663628 [PubMed - indexed for MEDLINE]Related articles

    9.

    The needle-borne HIV epidemic: causes and public health responses.

    Gostin L.

    Behav Sci Law. 1991 Summer;9(3):287-304.PMID: 10148824 [PubMed - indexed for MEDLINE]Related articles

    10.

    Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

    Case P, Beckett GA, Jones TS.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S94-101.PMID: 9663631 [PubMed - indexed for MEDLINE]Related articles

    11.

    A national physician survey on prescribing syringes as an HIV prevention measure.

    Macalino GE, Sachdev DD, Rich JD, Becker C, Tan LJ, Beletsky L, Burris S.

    Subst Abuse Treat Prev Policy. 2009 Jun 8;4:13.PMID: 19505336 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sterile injection equipment to prevent HIV infection.

    Robertson R.

    Ann Intern Med. 2001 Aug 21;135(4):299. No abstract available. PMID: 11511145 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.

    Sneed RC, May WL, Stencel C.

    Pediatrics. 2004 Nov;114(5):e612-25.PMID: 15520092 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Syringe prescription to prevent HIV infection in Rhode Island: a case study.

    Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S.

    Am J Public Health. 2001 May;91(5):699-700.PMID: 11344871 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Should pharmacists sell sterile syringes to injection drug users?

    Jones TS, Taussig J.

    J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):8-10. No abstract available. PMID: 9990178 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

    Wright-De Agüero L, Weinstein B, Jones TS, Miles J.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10.PMID: 9663632 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

    Singer M, Baer HA, Scott G, Horowitz S, Weinstein B.

    Public Health Rep. 1998 Jun;113 Suppl 1:81-9.PMID: 9722813 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey.

    Taylor LE, Runarsdottir V, Zampi A, Osei A, Sanford S, Macalino G, McKenzie M, Burris S, Gross JD, Reinert SE, Rich JD.

    J Addict Dis. 2003;22(1):67-78.PMID: 12661980 [PubMed - indexed for MEDLINE]Related articles

    19.

    In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users.

    Lazzarini Z, Schoenbaum EE, O'Neill CH.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S141-3. No abstract available. PMID: 9663639 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reducing the risk of HIV infection associated with illicit drug use.

    American Academy of Pediatrics Committee on Pediatric AIDS.

    Pediatrics. 2006 Feb;117(2):566-71.PMID: 16452382 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data